doxorubicin hydrochloride has been researched along with dehydrocostus lactone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Chen, Y; Ding, YH; Gao, X; Kuang, BJ; Long, J; Zhang, Q | 1 |
2 other study(ies) available for doxorubicin hydrochloride and dehydrocostus lactone
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Dispirocyclopropyldehydrocostus lactone selectively inhibits acute myelogenous leukemia cells.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Lactones; Leukemia, Myeloid, Acute; Mice; Mice, SCID; Neoplasms; Poly(ADP-ribose) Polymerases; Prodrugs; Sesquiterpenes; Transplantation, Heterologous; Up-Regulation | 2016 |